Literature DB >> 29139565

Leukocyte adhesion defect-I: rare primary immune deficiency.

Nitesh Tewari1, Vijay Prakash Mathur1, Vikender Singh Yadav2, Prabhat Chaudhari3.   

Abstract

Leukocyte adhesion defect I is a rare disorder (1:1,000,000) caused by diminished expression of CD-18 β2 integrins on leukocytes leading to abnormal adhesion, migration, and chemotaxis. Clinical manifestations include delayed separation of umbilical cord, omphalitis, recurrent severe infections, impaired wound healing, persistent oral ulcers, and severe periodontitis in primary and permanent dentition. A 5-year-old girl, second-born child to parents with consanguinity, presented with pain and mobility of lower teeth. There was history of recurrent infections and multiple hospital admissions with CD18 level-3% and frame shift mutation in ITGB2, on 21q22.3. There were scars on hands and feet. Oral examination revealed multiple missing teeth and periodontitis in primary dentition. Oral prophylaxis and palliative treatments were performed with periodic follow-ups. Interdisciplinary care is ubiquitous for patients with immune deficiencies. Early consultation with pediatric dentists and exploration of medical history is essential for diagnosis and treatment of rare diseases.
© 2017 Special Care Dentistry Association and Wiley Periodicals, Inc.

Entities:  

Keywords:  immunodeficiencies; quality of life; rare disorders

Mesh:

Year:  2017        PMID: 29139565     DOI: 10.1111/scd.12249

Source DB:  PubMed          Journal:  Spec Care Dentist        ISSN: 0275-1879


  2 in total

1.  Report of a Chinese Cohort with Leukocyte Adhesion Deficiency-I and Four Novel Mutations.

Authors:  Bijun Sun; Qiuyu Chen; Xiaolong Dong; Danru Liu; Jia Hou; Wenjie Wang; Wenjing Ying; Xiaoying Hui; Qinhua Zhou; Haili Yao; Jinqiao Sun; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2019-03-27       Impact factor: 8.317

2.  A novel ITGB2 variant with long survival in patients with leukocyte adhesion defect type-I.

Authors:  Mehmet Halil Celiksoy; Mustafa Yavuz Köker; Alper Gezdirici; Sevil Ozsoy; Baris Malbora; Songul Gungor
Journal:  Immunol Res       Date:  2021-08-01       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.